Milad Dagher

Nomic has partnered with Broad Clinical Labs to bring Omni 1000 into discovery and translational workflows. After profiling ~1M samples, we’re expanding access and embedding our platform into multi-omic & translational research. businesswire.com/news/home/2026…

Stoked to be finally announcing this. Byron’s company-building experience in the proteomics space is outstanding. Importantly, Byron shares our core belief in the massive impact proteomics will have on precision diagnostics and medicine. Welcome Byron!

We’re pleased to welcome Byron Hewett to our Board of Directors! As Nomic’s first Independent Director, Byron brings a wealth of operational and strategic expertise rooted in his experiences at the helm of companies like Somalogic. Welcome, Byron! businesswire.com/news/home/2023…

@zavaindar @nanli @AGoulburn What a line-up! Really excited for you @zavaindar and can't wait to see what you guys are going to do together

SOME NEWS: after a decade investing in the most brilliant interdisciplinary entrepreneurs on the planet, my best friends & partners @nanli @AGoulburn & I are joining forces on … *something new* ;) “If the path be beautiful, let us not ask where it leads.” - Anatole France

Are you at #slas2022 ? We are too! Come see our CEO @miladdag give a talk on the nELISA and its application to protein profiling in high-throughput screens. See it in person Tue, Feb 8th at 1pm, wait for it on-demand, or visit booth 2632. eventscribe.net/2022/SLAS2022/…

Excited to be partnering together with @zavaindar and to have the backing of @Lux_Capital as we set out to build the world's highest throughput protein profiling platform. Come help us transform the way scientists measure biology: tinyurl.com/nomicjobs

@Therence_mtl @nomicbio @frontrowvc Thanks for the kind words @Therence_mtl!

LFG!! 🚀 From Nature paper to revolutionizing proteomics, it’s been inspiring to follow @miladdag & @nomicbio over the last 3 years. Happy I was able to play a very small part in this story and back them at @frontrowvc

@srikosuri @celinehalioua There may be little that is average about a PI-turned-founder @srikosuri

@celinehalioua Ouch.

Unpopular opinion but - on average, scientists make bad founder-CEOs (without a lot of work) IMO the founder-led bio "movement" should focus more on getting general founder-types interested in building in bio - similar founder profile to what you see in other deeptech co's today

@mattkrisiloff At nplex (@nplexbio) we're building the world's highest throughput protein profiling platform; currently at 350,000 proteins/day and growing 5x / year. We're a team of nano/bioengineers and we're looking for automation and software engineers to join our team. Reach out!

'Science Startups - Who's Hiring?' A lot of scientists have a hard time finding cool startup opportunities. Trying an experiment to help. Science startups -- reply with 1 tweet on your mission, roles looking for, and how to learn more. Everyone -- RT so more scientists see!

Great advice from @snowmaker - most people spinning out their research typically learn these the hard way.

We're looking for assay analysts, bio/nano-engineers, automation engineers, and data scientists with a knack for immunology! Come scale our nanotech-driven platform and transform modern drug discovery pipelines. Check out all open opportunities here: angel.co/company/nplex-…

@MStephensGulf You have correctly listed the reasons (see "excuses"). But couldn't any other state do the same? More can and should be done.